These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3105962)

  • 1. Thyrotropin releasing hormone: effects in monkeys and dogs subjected to experimental circulatory shock.
    Gurll NJ; Holaday JW; Reynolds DG; Ganes E
    Crit Care Med; 1987 Jun; 15(6):574-81. PubMed ID: 3105962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorespiratory alterations produced by centrally administered thyrotropin-releasing hormone during canine endotoxin shock.
    Leffew SD; Williams CD; Janssen HF
    Circ Shock; 1987; 21(3):225-32. PubMed ID: 3105908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of thyrotropin-releasing hormone in canine hemorrhagic shock.
    Teba L; Zakaria M; Dedhia HV; Schiebel F; Beamer KC
    Circ Shock; 1987; 21(1):51-7. PubMed ID: 2949884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system is involved in the cardiovascular responses to naloxone in canine endotoxic but not hemorrhagic shock.
    Gurll NJ; Ganes E; Reynolds DG
    Circ Shock; 1987; 22(2):115-25. PubMed ID: 3594733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock.
    Zheng D; Chen HS; Hu DY
    Circ Shock; 1992 Mar; 36(3):169-73. PubMed ID: 1611701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin-releasing hormone (TRH) and circulatory shock.
    McIntosh TK; Faden AI
    Circ Shock; 1986; 18(3):241-58. PubMed ID: 3084122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of naloxone and thyrotropin-releasing hormone on plasma catecholamines, corticosterone, and arterial pressure in normal and endotoxemic rats.
    Long JB; Lake CR; Reid AA; Holaday JW
    Circ Shock; 1986; 18(1):1-10. PubMed ID: 3080257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of endorphins in the cardiovascular pathophysiology of primate shock.
    Gurll NJ; Reynolds DG; Holaday JW
    Crit Care Med; 1988 May; 16(5):521-30. PubMed ID: 2966036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone increases survival in canine hemorrhagic shock.
    Sugiura A; Smith RA; Shatney CH
    J Surg Res; 1986 Jan; 40(1):63-8. PubMed ID: 3079847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone in endotoxic shock: experimental models and clinical perspective.
    Gurll N
    Adv Shock Res; 1983; 10():63-71. PubMed ID: 6308974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beneficial effect of thyrotropin-releasing hormone in combination with HSD on hemorrhagic shock with pulmonary edema at high altitude in the rat].
    Hu DY; Liu LM; Li P; Liu JC; Liu HD; He YM; Huo XP; Tian KL; Shi QG; Xiao N; Zhou XW
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 May; 15(5):268-71. PubMed ID: 12837184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opiate receptors and endorphins in the pathophysiology of hemorrhagic shock.
    Gurll NJ; Vargish T; Reynolds DG; Lechner RB
    Surgery; 1981 Mar; 89(3):364-9. PubMed ID: 6258256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock.
    Dulchavsky SA; Lucas CE; Ledgerwood AM; Grabow D; Brown TR; Bagchi N
    Circ Shock; 1993 Jan; 39(1):68-73. PubMed ID: 8481977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent effects of nalbuphine in canine hemorrhagic shock.
    Hunt LB; Gurll NJ; Reynolds DG
    Circ Shock; 1984; 13(4):307-18. PubMed ID: 6090033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of vasoactive mediator antagonists on endotoxic shock in dogs. I.
    Toth PD; Hamburger SA; Judy WV
    Circ Shock; 1984; 12(4):277-86. PubMed ID: 6722995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin-releasing hormone on myocardial adrenoceptors and dopaminergic receptors following hemorrhagic shock in the rat.
    Liu LM; Chen HS; Hu DY; Lu RQ; Li TX
    Shock; 1995 Jun; 3(6):430-3. PubMed ID: 7656067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacological study of the cardiovascular effects of TRH-T in haemorrhagic shock in rats.
    Guarini S; Gherardi S; Calabrò G; Bertolini A
    Arch Int Pharmacodyn Ther; 1989; 299():65-76. PubMed ID: 2505701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone and TRH in the treatment of shock and trauma: what future roles?
    Bernton EW
    Ann Emerg Med; 1985 Aug; 14(8):729-35. PubMed ID: 3927793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of thyrotropin-releasing hormone in experimental hemorrhagic shock--cardiovascular mechanism.
    Zheng D; Chen HS; Hu DY
    J Tongji Med Univ; 1990; 10(3):187-92. PubMed ID: 1979356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone without transfusion prolongs survival and enhances cardiovascular function in hypovolemic shock.
    Gurll NJ; Reynolds DG; Vargish T; Lechner R
    J Pharmacol Exp Ther; 1982 Mar; 220(3):621-4. PubMed ID: 7062272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.